Cryopreservation, cryoprotectants, and potential risk of epigenetic alteration
Journal of Assisted Reproduction and Genetics · 2024-11 · 41 (11) · 2953-2967
DOI: 10.1007/s10815-024-03287-3 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Journal of Assisted Reproduction and Genetics, online erschienen am 22.10.2024. Verfasst von Romualdo Sciorio und 3 weiteren Autor:innen. Beteiligte Einrichtung: Fertility Medicine and Gynaecological Endocrinology Unit, Department Woman-Mother-Child, Lausanne University Hospital, Lausanne, Switzerland. Hauptthemen laut MEDLINE: Cryopreservation, Cryoprotective Agents, Epigenesis, Genetic, Reproductive Techniques, Assisted. Die Arbeit wurde bisher 29-mal zitiert (Crossref) und nennt 195 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
The cryopreservation of gametes and embryos has increased notably over the past 20 years and is now an essential part of assisted reproductive technologies (ARTs). However, because the cryopreservation process is un-physiological for human cells, gametes, and embryos, cryobiologists have suggested diverse methods to successfully cryopreserve human gametes and embryos in order to maintain their viability and assure successful pregnancy. During the first period of early development, major waves of epigenetic reprogramming-crucial for the fate of the embryo-occur. Recently, concerns relating to the increased incidence of epigenetic anomalies and genomic-imprinting disorders have been reported after ARTs and cryopreservation. Epigenetic reprogramming is particularly susceptible to environmental and un-physiological conditions such as ovarian stimulation, embryo culture, and cryopreservation that might collectively affect epigenetics dysregulation. Additionally, recent literature suggests that epigenetic and transcriptomic profiles are sensitive to the stress induced by vitrification, osmotic shock, oxidative stress, rapid temperature and pH changes, and cryoprotectants; it is therefore critical to have a more comprehensive understanding of the potential induced perturbations of epigenetic modifications that may be associated with vitrification. The aim of this paper is to present a critical evaluation of the association of gamete and embryo cryopreservation, use of cryoprotectants, and epigenetic dysregulations with potential long-term consequences for offspring health.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Fertility Medicine and Gynaecological Endocrinology Unit, Department Woman-Mother-Child, Lausanne University Hospital, Lausanne, Switzerland.
- Department of Advanced Reproductive Risk Management and High-Risk Pregnancies, ASL Bari, Reproductive and IVF Unit, PTA Conversano, Conversano, BA, Italy.
- Departments of Obstetrics and Gynecology, Physiology, and Urology and Reproductive Sciences Program, University of Michigan, 4742F Medical Sciences II, 1301 E. Catherine Street, Ann Arbor, MI, 48109-056171500, USA. smit…
Zitieren
APA
Sciorio, R., Cantatore, C., D'Amato, G., & Smith, G. D. (2024). Cryopreservation, cryoprotectants, and potential risk of epigenetic alteration. Journal of Assisted Reproduction and Genetics, 41(11), 2953-2967. https://doi.org/10.1007/s10815-024-03287-3
Vancouver
Sciorio R, Cantatore C, D'Amato G, Smith GD. Cryopreservation, cryoprotectants, and potential risk of epigenetic alteration. Journal of Assisted Reproduction and Genetics. 2024;41(11):2953-2967. doi:10.1007/s10815-024-03287-3
BibTeX
@article{Sciorio2024,
author = {Sciorio, Romualdo and Cantatore, Clementina and D'Amato, Giuseppe and Smith, Gary D},
title = {Cryopreservation, cryoprotectants, and potential risk of epigenetic alteration},
journal = {Journal of Assisted Reproduction and Genetics},
year = {2024},
volume = {41},
number = {11},
pages = {2953--2967},
doi = {10.1007/s10815-024-03287-3}
}
EUVIMED